Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06528418 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Collaborators: 4 to 14v3
  2. Collaborators: 3 to 4v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
ChromX Health
2 trials monitored
See all monitored trials
Lung Cancer
4,790 trials monitored
See 263 trials at risk
Hypertension
1,925 trials monitored
See 99 trials at risk
COPD
1,119 trials monitored
See 34 trials at risk
and 2 more diseases
The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecules. This model aims to accurately diagnose mutiple pulmonary diseases. The primary objectives it strives to accomplish are: 1. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose several common pulmonary diseases. 2. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose more pulmonary diseases.
Trial Details
NCT Number NCT06528418
Lead Sponsor ChromX Health
Collaborators: The First Affiliated Hospital of Guangzhou Medical University, First People's Hospital of Foshan, Sichuan Cancer Hospital and Research Institute, Liwan District Central Hospital, Shanghai Chest Hospital, Peking Union Medical College Hospital, Guangzhou Development Zone Hospital, Huangpu District Hongshan Street Community Health Service Center, Huangpu District Chinese Medicine Hospital, Fifth Affiliated Hospital of Guangzhou Medical University, Huangpu District Jiufo Street Community Health Service Center, Huangpu District Xinlong Town Central Hospital, Huangpu District Yonghe Street Community Health Service Center, Huangpu District Lianhe Street Second Community Health Service Center
Conditions
(from sponsor)		 Lung Cancer, Lung Infection, COPD, Bronchitis, Pulmonary Fibrosis, Pulmonary Embolism, Pulmonary Arterial Hypertension, Pulmonary Tuberculosis +8 more
Related terms Asthma, Bronchiectasis, Bronchitis, Cystic Fibrosis, Emphysema, Lung Abscess, Lung Diseases, Lung Diseases, Interstitial, Lung Injury, Lung Neoplasms, Pulmonary Arterial Hypertension, Pulmonary Disease, Chronic Obstructive, Pulmonary Embolism, Pulmonary Fibrosis, Tuberculosis, Pulmonary
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov